Peripheral T-cell lymphoma (PTCL) is defined as a diverse group of aggressive lymphomas that develop from mature-stage white blood cells called T-cells and natural killer (NK) cells.

No consensus exists on the best therapeutic strategy for relapsed/refractory Peripheral T-Cell Lymphoma (PTCL). Since 2009, there have been three agents approved for people with PTCL …

Peripheral T-cell lymphoma (PTCL) refers to more than eight different T-cell lymphomas (TCLs) that, together, account for about four percent of all patients diagnosed with NHL in the United …

Angioimmunoblastic T-cell lymphoma (AITL) is a rare and often fast-growing form of peripheral T-cell lymphoma (PTCL). It accounts for about 20-30% of PTCLs and is more common in older …

Lymphomas that arise from mature T cells are sometimes categorized together under the general term peripheral T-cell lymphoma (PTCL), which distinguishes them from the lymphoma that …

Lymphomas that arise from mature T cells are sometimes categorized together under the general term peripheral T-cell lymphoma (PTCL), which distinguishes them from the lymphoma that …

cell lymphomas appear from mature T-cells (T-cells that are fully developed). T-cell lymphomas can be aggressive (fast-growing) or indolent (slow-growing) and are mainly found in the skin …

For most subtypes of peripheral T-cell lymphoma (PTCL), the initial treatment is typically a combination chemotherapy regimen, such as CHOP (cyclophosphamide, doxorubicin, …

Patients with PTCL should have regular visits with their physician. During these visits, medical tests (such as blood tests, computed tomography [CT] scans, and positron emission …

2024年9月5日 · Better therapies are needed for patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), and Dr. Shea’s research aims to identify a novel, improved treatment …